Argenx
ARGX
#411
Rank
NZ$98.36 B
Marketcap
NZ$1,579
Share price
1.19%
Change (1 day)
50.94%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report